View PDF Version - RePub - Erasmus Universiteit Rotterdam

Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE (1990) An
internal deletion within an IIp!3 zinc finger gene contributes to the development of Wilms' tumor. Cell
61:1257-1269.
Haber DA, Housman DE (1992) The genetics of Wilms' tumor. Adv Cancer Res 59:41-68.
Hagemeijer A, Versnel MA, van Drunen E, Moret M, Douts MJ, van der Kwast Th H, Hoogsteden HC (1990)
Cytogenetic analysis of malignant mesothelioma. Cancer Genet Cytogenet47:1-28.
Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ (1988) Abnormalities in structure and
expression of the human relinoblsloma gene in SCLC. Science 241:353-357.
Harper JW, Adami OR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cipl is a
potent inhibitorofGI eyelin-dependent kinases. Cell 75:805-816.
Harris H (1988) The analysis of malignancy by cell fusion: the position in 1988. Cancer Res 48:3302-3306.
Harris L (1992) p53 expression in human breast cancer. Adv in Cancer Res 59:69-88.
Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med
329: 1318-1327.
Henry It Grandjouan S, Couillin P, Darichard F, Huerre-Jeanpierre C, Glaser T. Lenoir G et al. (1989) Tumorspecific
loss of IlpIS.S alleles in deillpl3 Wilms tumor and in familial adrenocortical carcinoma. Proc Nat!
Acad Sci USA 86: 3247-3251.
Hensel CH, Hsieh CL, Gazdar AF, Johnson DE, Sakaguchi AY, Naylor SL, Lee WH, Lee EY (1990) Altered
structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res
50:3067-3072.
van Heyningen V, Hastie ND (1992) Wilms' tumour: reconciling genetics and biology. TiO 8:16-21.
Hofstra RMW, Landsvater RM, Ceccherini T, Stulp RP, Stelwagen T. Luo Y. Pasini B et al. (1994) A mutation
in the RET proto-oncogene associated with mUltiple endocrine neoplasia type 2B and sporadic medullary thyroid
carcinoma. Nature 367:375-376.
Hollstein M, Sidransky D, Vogelstein B. Harris CC. (1991) p53 mutations in human cancers. Science 253:49-
52.
Huang HJS, Yee JY, Shew JY, Chen PL, Bookstein R, Friedmann T, Lee EYHP, Lee WH (1988) Suppression
of the neoplastic phenotype by replacement of the Rb gene in human cancer cells. Science 242: 1563-1566.
Huff V, Miwa H, Haber DA, Call KM, Housman DE, Strong Le, Saunders GF (1991) Evidence for WTl as
a Wilms tumor (WT) gene: inlragenic germinal deletion in bilateral WT. Am J Hum Genet 48:997-1003.
Hunter T (1991) Cooperation between oncogenes. Cell 64: 249-270.
Hupp TR, Meek DW, Midgley CA, Lane DP (1992) Regulation of the specific DNA binding function of p53.
Cell 71:875-886.
JiiliskeliHnen J, Haltia M, Laasonen E, Wahlstrom T, Valtonen S (1985) The growth rate of intracranial
meningiomas and its relation to histology. Surg Neurol 24: 165-172.
Jacohy LB, MacCollin M, Louis DN, Mohney T, Rubio MP, Pulaski K, Trofatter JA et al. (1994) Exon
scanning for mutations of the NF2 gene in schwannomas. HUIll Mol Genet 3:413-419.
James CD, He J, Carlbom E, Mikkelsen T, Ridderheim, Cavenee WK, Collins VP (1990) Loss of genetic
information in central nervous system hlfllOrs common to children and young adults. Genes Chrom Cancer 2:94-
102.
Jenkins RB, Kinmlei DW, Moertel CA, Schultz CG, Scheithauer BW, Kelly PJ, Dewald GW (1989) A
cylogenetic study of 53 human gliomas. Cancer Genet Cytogenet 39:253-279.
Johnson MR, Look AT, DeClue JE, Valentine MD, Lowy DR (1993) Inactivation of the NFl gene in human
melanoma and neuroblastoma cell line-s without impaired regulation of GTP-Ras. Proc Nat! Acad Sci USA
90:5539-5543.
de Jong PJ, Yokobata K, Chen C, Lohman F, Pederson L, McNinch J, van Dilla M (1989) Human
chromosome-spedfic partial digest libraries in k and cos mid vectors. Cylogenet Cell Genet 51:985.
45